Notice is hereby given that as of 1 April 2023, payment of the tariffs referred to in the Ministerial Decree of 6 December 2016 must be made exclusively through the "PagoPA" channel. 

Therefore, pharmaceutical companies are invited to prefer this method of payment in order to reduce the management time by AIFA and guarantee the immediacy of collection, automatically reconcile payments with debt positions, save resources and ensure traceability.

Companies that do not have a current account enabled for PagoPA payments will be able to use the Paypal channel.

For further details please refer to the attached document and the user manual available in the appropriate section within the POL application.